National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 61722-61723 [2011-25635]

Download as PDF 61722 Federal Register / Vol. 76, No. 193 / Wednesday, October 5, 2011 / Notices Name of Committee: Center for Scientific Review Special Emphasis Panel, Small Business Grant Applications: Immunology. Date: October 24–25, 2011. Time: 8:30 a.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: One Washington Circle Hotel, One Washington Circle, Washington, DC 20037. Contact Person: Stephen M Nigida, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4212, MSC 7812, Bethesda, MD 20892, 301–435– 1222, nigidas@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Review Group, Neurological Sciences and Disorders C. Date: October 20–21, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate contract proposals. Place: The West Chicago Lakeshore Hotel, 644 North Lakeshore Drive, Chicago, IL 60611. Contact Person: William C. Benzing, Ph.D., Scientific Review Officer, DHHS/NIH/ NINDS/DER/SRB, 6001 Executive Boulevard, MSC 9529, Neuroscience Center, Room 3208, Bethesda, MD 20892, 301–496–0660, benzingw@mail.nih.gov. Name of Committee: National Institute of Neurological Disorders and Stroke Initial Review Group, Neurological Sciences and Disorders A. Date: November 2–3, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate contract proposals. Place: Embassy Suites, Washington, DC, 1250 22nd Street, Washington, DC 20037. Contact Person: Richard D. Crosland, Ph.D., Scientific Review Officer, DHHS/NIH/ NINDS/DER/SRB, 6001 Executive Boulevard, MSC 9529, Neuroscience Center, Room 3208, Bethesda, MD 20892, 301–496–9223. (Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS) Dated: September 27, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. Dated: September 27, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–25639 Filed 10–4–11; 8:45 am] [FR Doc. 2011–25634 Filed 10–4–11; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Initial Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin mstockstill on DSK4VPTVN1PROD with NOTICES The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. VerDate Mar<15>2010 19:11 Oct 04, 2011 Jkt 226001 PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 Diseases Special Emphasis Panel, Career Development, Research Training & Pathways to Independence Review. Date: October 25, 2011. Time: 10 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Charles H Washabaugh, PhD, Scientific Review Officer, Scientific Review Branch, National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health, 6701 Democracy Blvd, Suite 800, Bethesda, MD 20817, 301–594–4952, washabac@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS) Dated: September 27, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–25638 Filed 10–4–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Data Coordinating Center for the Cardiovascular Cell Therapy Research Network. Date: October 24, 2011. Time: 8 a.m. to 9:30 a.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Kristin Goltry, PhD, Scientific Review Officer, Review Branch, DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7198, E:\FR\FM\05OCN1.SGM 05OCN1 mstockstill on DSK4VPTVN1PROD with NOTICES Federal Register / Vol. 76, No. 193 / Wednesday, October 5, 2011 / Notices Bethesda, MD 20892, 301–435–0297, goltrykl@mail.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Regional Clinical Center for the Cardiovascular Cell Therapy Research Network. Date: October 24–25, 2011. Time: 9:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Kristin Goltry, PhD, Scientific Review Officer, Review Branch, DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7198, Bethesda, MD 20892, 301–435–0297, goltrykl@mail.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Protein Capture Agents for Cardiovascular Research. Date: October 24, 2011. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate contract proposals. Place National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: David A Wilson, PhD, Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7204, Bethesda, MD 20892–7924, 301–435– 0299, wilsonda2@nhlbi.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Translational Programs in Lung Diseases. Date: October 26–27, 2011. Time: 6 p.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Susan Wohler Sunnarborg, PhD, Scientific Review Officer, Office of Scientific Review/DERA, National, Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7185, Bethesda, MD 20892, sunnarborgsw@nhlbi.nih.gov. Name of Comittee: National Heart, Lung, and Blood Institute Special Emphasis Panel, Genomic Research in AAT-Deficiency and Sarcoidosis—Clinical Centers. Date: October 26–27, 2011. Time: 12:30 p.m. to 9 a.m. Agenda: To review and evaluate grant applications. Place: Churchill Hotel, 1914 Connecticut Avenue, NW., Washington, DC 20009. Contact Person: William J. Johnson, PhD, Scientific Review Officer, Office of Scientific Review/DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7178, Bethesda, MD 20892–7924, 301–435– 0725, johnsonwj@nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) VerDate Mar<15>2010 19:11 Oct 04, 2011 Jkt 226001 Dated: September 28, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–25635 Filed 10–4–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Office of the Secretary Agency Information Collection Activities: Minimum Standards for Driver’s Licenses and Identification Cards Acceptable by Federal Agencies for Official Purposes Department of Homeland Security. ACTION: 30-Day Notice and request for comments; Revision of a currently approved collection. AGENCY: The Department of Homeland Security, Office of the Secretary, will submit the following information collection request (ICR) to the Office of Management and Budget (OMB) for review and clearance in accordance with the Paperwork Reduction Act of 1995 (P.L. 104–13, 44 U.S.C. chapter 35). DHS previously published this information collection request (ICR) in the Federal Register on July 18, 2011 at 76 FR 42132, for a 60-day public comment period. No comments were received by DHS. The purpose of this notice is to allow an additional 30-days for public comments. DATES: Comments are encouraged and will be accepted until November 4, 2011. This process is conducted in accordance with 5 CFR 1320.10. ADDRESSES: Interested persons are invited to submit written comments on the proposed information collection to the Office of Information and Regulatory Affairs, Office of Management and Budget. Comments should be addressed to OMB Desk Officer, Department of Homeland Security and sent via electronic mail to oira_submission@omb.eop.gov or faxed to (202) 395–5806. The Office of Management and Budget is particularly interested in comments which: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, SUMMARY: PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 61723 including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; and 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses. FOR FURTHER INFORMATION CONTACT: If additional information is required contact: Office of the Secretary, DHS Attn.: Steve Kozar Steven.Kozar@hq.dhs.gov, (202) 447– 3368. SUPPLEMENTARY INFORMATION: The REAL ID Act of 2005 (the Act) prohibits federal agencies from accepting stateissued drivers’ licenses or identification cards for any official purpose—defined by the Act and regulations as boarding commercial aircraft, accessing federal facilities, or entering nuclear power plants—unless the license or card is issued by a state that meets the requirements set forth in the Act. Title II of Division B of Public Law 109–13, codified at 49 U.S.C. 30301 note. The REAL ID regulations, which DHS issued in January 2008, establish the minimum standards that states must meet to comply with the Act. See 73 FR 5272, also 6 CFR part 37 (Jan. 29, 2008). These include requirements for presentation and verification of documents to establish identity and lawful status, standards for document issuance and security, and physical security requirements for driver’s license production facilities. For a state to achieve full compliance, the Department of Homeland Security (DHS) must make a final determination on or before January 15, 2013, that the state has met the requirements contained in the regulations and is compliant with the Act. The regulations include new information reporting and record keeping requirements for states seeking a full compliance determination by DHS. As discussed in more detail below, states seeking DHS’s full compliance determination must certify that they are meeting certain standards in the issuance of driver’s licenses and identification cards and submit security plans covering physical security of document production and storage facilities as well as security of personally identifiable information. 6 CFR 37.55(a). States also must conduct background checks and training for employees involved in the document E:\FR\FM\05OCN1.SGM 05OCN1

Agencies

[Federal Register Volume 76, Number 193 (Wednesday, October 5, 2011)]
[Notices]
[Pages 61722-61723]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-25635]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel, Data Coordinating Center for the 
Cardiovascular Cell Therapy Research Network.
    Date: October 24, 2011.
    Time: 8 a.m. to 9:30 a.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Kristin Goltry, PhD, Scientific Review Officer, 
Review Branch, DERA, National Heart, Lung, and Blood Institute, 6701 
Rockledge Drive, Room 7198,

[[Page 61723]]

Bethesda, MD 20892, 301-435-0297, goltrykl@mail.nih.gov.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel, Regional Clinical Center for the 
Cardiovascular Cell Therapy Research Network.
    Date: October 24-25, 2011.
    Time: 9:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Kristin Goltry, PhD, Scientific Review Officer, 
Review Branch, DERA, National Heart, Lung, and Blood Institute, 6701 
Rockledge Drive, Room 7198, Bethesda, MD 20892, 301-435-0297, 
goltrykl@mail.nih.gov.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel, Protein Capture Agents for Cardiovascular 
Research.
    Date: October 24, 2011.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate contract proposals.
    Place National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: David A Wilson, PhD, Scientific Review Officer, 
Office of Scientific Review/DERA, National Heart, Lung, and Blood 
Institute, 6701 Rockledge Drive, Room 7204, Bethesda, MD 20892-7924, 
301-435-0299, wilsonda2@nhlbi.nih.gov.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel, Translational Programs in Lung Diseases.
    Date: October 26-27, 2011.
    Time: 6 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Susan Wohler Sunnarborg, PhD, Scientific Review 
Officer, Office of Scientific Review/DERA, National, Heart, Lung, 
and Blood Institute, 6701 Rockledge Drive, Room 7185, Bethesda, MD 
20892, sunnarborgsw@nhlbi.nih.gov.

    Name of Comittee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel, Genomic Research in AAT-Deficiency and 
Sarcoidosis--Clinical Centers.
    Date: October 26-27, 2011.
    Time: 12:30 p.m. to 9 a.m.
    Agenda: To review and evaluate grant applications.
    Place: Churchill Hotel, 1914 Connecticut Avenue, NW., 
Washington, DC 20009.
    Contact Person: William J. Johnson, PhD, Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, 6701 Rockledge Drive, Room 7178, Bethesda, MD 
20892-7924, 301-435-0725, johnsonwj@nhlbi.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: September 28, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-25635 Filed 10-4-11; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.